Date of Award
1-1-2016
Language
English
Document Type
Dissertation
Degree Name
Doctor of Philosophy (PhD)
College/School/Department
Department of Nanoscale Science and Engineering
Program
Nanoscale Engineering
Content Description
1 online resource (xix, 211 pages) : illustrations (some color)
Dissertation/Thesis Chair
Magnus Bergkvist
Committee Members
Xinxin Ding, Benoit Boivin, Susan Sharfstein, Nadine Hempel
Keywords
Drug Delivery, Glycogen, Nanotechnology, Photodynamic Therapy, siRNA, Drug delivery systems, Dendrimers, Nanostructured materials, Small interfering RNA
Subject Categories
Biochemistry | Biomedical Engineering and Bioengineering | Pharmacy and Pharmaceutical Sciences
Abstract
The field of medicinal chemistry is ever expanding, designing and discovering new therapeutic strategies. Oftentimes, it is challenging for these therapeutics to undergo clinical translation due to ineffective administration or unwanted toxicity in vivo. As such, drug delivery vehicles are designed to overcome these hurdles, allowing for delivery to the site of action by improving biodistribution, protecting therapeutic cargo, and decreasing toxicity. The work presented here aims to investigate a naturally-derived carbohydrate nanodendrimer, enzymatically synthesized glycogen (ESG) for drug delivery. This nontoxic, highly-branched, glucose-based structure has interior void volumes to allow for cargo encapsulation as well as a large density of surface functionalities for chemical functionalization.
Recommended Citation
Engelberth, Sarah Ann, "Investigation of enzymatically synthesized glycogen as a novel nanodendrimer for therapeutic delivery" (2016). Legacy Theses & Dissertations (2009 - 2024). 1604.
https://scholarsarchive.library.albany.edu/legacy-etd/1604
Included in
Biochemistry Commons, Biomedical Engineering and Bioengineering Commons, Pharmacy and Pharmaceutical Sciences Commons